Date

Friday, 14 June 2024

Location

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

This one-day hybrid Big Data Steering Group (BDSG) workshop will bring together representatives of regulatory agencies, pharmaceutical companies, patients, healthcare professionals, academia, and health technology assessment bodies to address the following objectives:

  • Hear the views of stakeholders and experts: 
    • on the draft RWE reflection paper expected to be open for public consultation in May 2024. 
    • on priorities for further regulatory guidance development and collaboration beyond the reflection paper.
  • Engage with stakeholders on RWE methods in regulatory decision making.

Registration

You can register for the workshop at the following link:

Registration for the Joint HMA/EMA Big Data Steering Group Workshop on RWE methods

  • Registration for in-house participation will close on 23 May 2024. In-house participation will be confirmed by 27 May 2024 and will be based on the capacity of the venue and distribution amongst several stakeholders.
  • Registration for online participation will remain open until 5 June 2024.

Documents

How useful do you find this page?